Correlation Between Karyopharm Therapeutics and Mind Medicine

Can any of the company-specific risk be diversified away by investing in both Karyopharm Therapeutics and Mind Medicine at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Karyopharm Therapeutics and Mind Medicine into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Karyopharm Therapeutics and Mind Medicine, you can compare the effects of market volatilities on Karyopharm Therapeutics and Mind Medicine and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Karyopharm Therapeutics with a short position of Mind Medicine. Check out your portfolio center. Please also check ongoing floating volatility patterns of Karyopharm Therapeutics and Mind Medicine.

Diversification Opportunities for Karyopharm Therapeutics and Mind Medicine

-0.16

Correlation Coefficient

Karyopharm Therapeutics  Mind Medicine

Good diversification

The 3 months correlation between Karyopharm and Mind is -0.16. Overlapping area represents the amount of risk that can be diversified away by holding Karyopharm Therapeutics and Mind Medicine in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mind Medicine and Karyopharm Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Karyopharm Therapeutics are associated (or correlated) with Mind Medicine. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mind Medicine has no effect on the direction of Karyopharm Therapeutics i.e., Karyopharm Therapeutics and Mind Medicine go up and down completely randomly.

Pair Corralation between Karyopharm Therapeutics and Mind Medicine

Given the investment horizon of 90 days Karyopharm Therapeutics is expected to under-perform the Mind Medicine. But the stock apears to be less risky and, when comparing its historical volatility, Karyopharm Therapeutics is 1.05 times less risky than Mind Medicine. The stock trades about -0.09 of its potential returns per unit of risk. The Mind Medicine is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest  569.00  in Mind Medicine on September 28, 2024 and sell it today you would earn a total of  163.00  from holding Mind Medicine or generate 28.65% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Karyopharm Therapeutics  vs.  Mind Medicine

Karyopharm Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Karyopharm Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in January 2025. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.

Mind Medicine

Risk-Adjusted Performance

8 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Mind Medicine are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady primary indicators, Mind Medicine exhibited solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Karyopharm Therapeutics and Mind Medicine

The main advantage of trading using opposite Karyopharm Therapeutics and Mind Medicine positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Karyopharm Therapeutics position performs unexpectedly, Mind Medicine can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mind Medicine will offset losses from the drop in Mind Medicine's long position.

The idea behind Karyopharm Therapeutics and Mind Medicine pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.